Title : Cholinesterase inhibitors for Alzheimer's disease.

Pub. Date : 2006 Jan 25

PMID : 16437532






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MAIN RESULTS: The results of 13 randomized, double blind, placebo controlled trials demonstrate that treatment for periods of 6 months and one year, with donepezil, galantamine or rivastigmine at the recommended dose for people with mild, moderate or severe dementia due to Alzheimer"s disease produced improvements in cognitive function, on average -2.7 points (95%CI -3.0 to -2.3), in the midrange of the 70 point ADAS-Cog Scale. Galantamine alkylglycerone phosphate synthase Homo sapiens